本页面由Tiger Trade Technology Pte. Ltd.提供服务

Sigilon Therapeutics, Inc.

22.47
0.0000
成交量:- -
成交额:187.79万
市值:5,650.08万
市盈率:-1.86
高:22.47
开:22.47
低:22.47
收:22.47
52周最高:28.00
52周最低:3.77
股本:251.45万
流通股本:148.61万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-12.1095
每股收益(LYR):-17.4750
净资产收益率:-76.31%
总资产收益率:-23.65%
市净率:2.06
市盈率(LYR):-1.29

数据加载中...

2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/12

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/08/12

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/08/11

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/11

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/08/11

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/07

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/06/29

重要事件披露

Form 8-K - Current report
2023/05/23

重要事件披露

Form 8-K - Current report
2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/09

重要事件披露

8-K - Current report
2023/03/14

重要事件披露

8-K - Current report
2023/03/14

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/14

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/10

重要事件披露

8-K - Current report
2023/02/28

重要事件披露

8-K - Current report
2023/02/13

重要事件披露

8-K - Current report